# Virtue® SAB in the Treatment of Coronary ISR Trial

> **NCT07045194** · NA · RECRUITING · sponsor: **Orchestra BioMed, Inc** · enrollment: 740 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Virtue Sirolimus AngioInfusion Balloon
- **DEVICE:** AGENT™ Paclitaxel Drug-Coated Balloon

## Key facts

- **NCT ID:** NCT07045194
- **Lead sponsor:** Orchestra BioMed, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-20
- **Primary completion:** 2028-10
- **Final completion:** 2032-10
- **Target enrollment:** 740 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045194, "Virtue® SAB in the Treatment of Coronary ISR Trial". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07045194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*